These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5923598)

  • 1. Adrenal cortical carcinoma. Clinical features of 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):572-80. PubMed ID: 5923598
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of adrenocortical cancer treated with O,P'-DDD.
    Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
    Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone and androstenedione production rates in patients with metastatic adrenal cortical carcinoma.
    Bardin CW; Lipsett MB; French AM
    J Clin Endocrinol Metab; 1968 Feb; 28(2):215-20. PubMed ID: 5636152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of a Cushing syndrome caused by hyperplasia of the adrenal cortex in a 7-year old girl with the adrenal cortex blocking agent opDDD ].
    Pichler E
    Helv Paediatr Acta; 1966 Nov; 21(5):447-74. PubMed ID: 5995803
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminoglutethimide in functioning adrenal carcinoma: case report.
    Kumar RS; Kamitsuna S; Cole VW
    South Med J; 1969 Feb; 62(2):225-7. PubMed ID: 5766457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carcinoma of the adrenal cortex].
    Dzhurin DS; Michin IV; Popovich S; Manoĭlovich DL; Dzhordzhevich P
    Probl Endokrinol (Mosk); 1974; 20(3):51-6. PubMed ID: 4375811
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical management of adrenocortical tumors with Cushing's syndrome.
    Scott HW; Foster JH; Rhamy RK; Klatte E; Liddle GW
    Ann Surg; 1971 Jun; 173(6):892-905. PubMed ID: 4325382
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
    Gustafsson JA; Lisboa BP
    Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adrenal Cushing's syndrome: clinico-pathologic review of 18 cases].
    Gómez-Huelgas R; Martín-Jiménez L; Valdivielso L; Collazos J; Renedo G; Ramos F; Arrieta F; Oliva H; Herrera Pombo JL
    Rev Clin Esp; 1984 Feb; 172(4):211-7. PubMed ID: 6739878
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone-secreting tumors of the adrenal cortex in children.
    Hayles AB; Hahn HB; Sprague RG; Bahn RC; Priestley JT
    Pediatrics; 1966 Jan; 37(1):19-25. PubMed ID: 4285417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of Cushing's syndrome in a 15-year-old boy caused by adrenal carcinoma].
    Pawlikowski T; Zieleniewski J; Zarzycki J; Jezewska-Musial M
    Endokrynol Pol; 1971; 22(3):259-60. PubMed ID: 5565009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of carcinoma on the site of compensatory-hyperplastic adrenal cortex regeneration].
    Rückert U
    Chirurg; 1970 Sep; 41(9):417-9. PubMed ID: 5471023
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome in infancy.
    Loridan L; Senior B
    J Pediatr; 1969 Sep; 75(3):349-59. PubMed ID: 5804181
    [No Abstract]   [Full Text] [Related]  

  • 18. [Negative responses to metopirone in Cushing's syndrome due to adrenal cortex adenoma or adenomatosis].
    de Gennes JL; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1971; 52(4):601-7. PubMed ID: 4333286
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP; Earll JM; Forsham PH
    Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.